Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2021 Filed May 5, 2021 16:15 UTC |
Troutman William WilsonCFO and Secretary
|
GrantStock Option(Right to buy) · Derivative | 125,000 | $0.00 Strike: $8.61 | $0.00 |
DisclosureSEC source: 0001493152-21-010522 · ownership.xml · derivative · entry 1 Troutman William Wilson · CIK 0001756102 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 656,200 Underlying: Common Stock · 125,000 shares Expires 2031-05-03 F1 · derivative.exercise_date: The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2025. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:16 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
GrantStock Option(Right to buy) · Derivative | 245,000 | $0.00 Strike: $8.61 | $0.00 |
DisclosureSEC source: 0001493152-21-010524 · ownership.xml · derivative · entry 1 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,185,000 Underlying: Common Stock · 245,000 shares Expires 2031-05-03 F1 · derivative.exercise_date: The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2023. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:15 UTC |
MAIER PAUL VDirector
|
GrantStock Option(Right to buy) · Derivative | 19,655 | $0.00 Strike: $8.61 | $0.00 |
DisclosureSEC source: 0001493152-21-010523 · ownership.xml · derivative · entry 1 MAIER PAUL V · CIK 0001182615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,555 Underlying: Common Stock · 19,655 shares Expires 2031-05-03 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on May 3, 2022. Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 23:55 UTC |
HARROW, INC.10% owner
|
SaleCommon Stock | 1,518,000 | $7.00 | $10,626,000.00 |
DisclosureSEC source: 0001493152-21-008584 · ownership.xml · nonDerivative · entry 1 HARROW HEALTH, INC. · CIK 0001360214 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,982,000 F1 · security: On April 12, 2021, Harrow Health, Inc., a Delaware corporation (the "Company"), closed the previously announced underwritten public offering of 1,518,000 shares of common stock of Eton Pharmaceuticals, Inc. at a public offering price of $7.00 per share, including 198,000 shared issued pursuant to the full exercise by the underwriter, National Securities Corporation, of its over-allotment option. The gross proceeds to the Company from the offering were approximately $10.6 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. Read SEC document |
| October 16, 2020 Filed Oct 17, 2020 01:30 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 15,000 | $7.00 | $105,000.00 |
DisclosureSEC source: 0001493152-20-019587 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 155,000 F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| October 16, 2020 Filed Oct 17, 2020 01:30 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 385,000 | $7.00 | $2,695,000.00 |
DisclosureSEC source: 0001493152-20-019587 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 3,885,000 F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| March 19, 2020 Filed Feb 16, 2021 13:59 UTC |
CASAMENTO CHARLES JDirector
|
GiftCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-003826 · ownership.xml · nonDerivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,420 Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:56 UTC |
CASAMENTO CHARLES JDirector
|
GrantStock Option (Right to buy) · Derivative | 27,400 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001493152-20-004058 · ownership.xml · derivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Common Stock · 27,400 shares Expires 2030-03-11 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:52 UTC |
RIEDEL NORBERT GDirector
|
GrantStock Option (Right to buy) · Derivative | 27,400 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001493152-20-004053 · ownership.xml · derivative · entry 1 RIEDEL NORBERT G · CIK 0001161662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Common Stock · 27,400 shares Expires 2030-03-11 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 16:56 UTC |
Troutman William WilsonCFO, Treasurer & Secretary
|
GrantStock Option (Right to buy) · Derivative | 186,200 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001493152-20-004059 · ownership.xml · derivative · entry 1 Troutman William Wilson · CIK 0001756102 · CFO, Treasurer & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,200 Underlying: Common Stock · 186,200 shares Expires 2030-03-11 F1 · derivative.exercise_date: The shares subject to the option shall vest in 48 equal monthly installments form the date of grant until fully vested and exercisable on March 12, 2024. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:58 UTC |
BAUM MARK LDirector
|
GrantStock Option (Right to buy) · Derivative | 27,400 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001493152-20-004062 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Common Stock · 27,400 shares Expires 2030-03-11 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:54 UTC |
MAIER PAUL VDirector
|
GrantStock Option (Right to buy) · Derivative | 27,400 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001493152-20-004056 · ownership.xml · derivative · entry 1 MAIER PAUL V · CIK 0001182615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Common Stock · 27,400 shares Expires 2030-03-11 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:52 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
GrantStock Option (Right to buy) · Derivative | 490,000 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001493152-20-004052 · ownership.xml · derivative · entry 1 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2030-03-11 F1 · derivative.exercise_date: The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on March 12, 2022. Read SEC document |
| August 13, 2019 Filed Aug 13, 2019 20:04 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
PurchaseCommon Stock | 5,000 | $6.15 | $30,750.00 |
DisclosureSEC source: 0001209191-19-045738 · doc4.xml · nonDerivative · entry 1 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,025,000 Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 20:17 UTC |
CASAMENTO CHARLES JDirector
|
PurchaseCommon Stock | 3,500 | $6.11 | $21,369.95 |
DisclosureSEC source: 0001209191-19-045498 · doc4.xml · nonDerivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,920 F1 · price: The range of purchase prices paid is $6.10 to $6.11. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:25 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
PurchaseCommon Stock | 8,600 | $7.96 | $68,431.06 |
DisclosureSEC source: 0001209191-19-032054 · doc4.xml · nonDerivative · entry 2 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:25 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
PurchaseCommon Stock | 1,400 | $7.78 | $10,894.80 |
DisclosureSEC source: 0001209191-19-032054 · doc4.xml · nonDerivative · entry 1 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011,400 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.77 to $7.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| February 20, 2019 Filed Mar 8, 2019 21:33 UTC |
CASAMENTO CHARLES JDirector
|
GrantStock option (right to buy) · Derivative | 12,500 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-19-018114 · doc4.xml · derivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-02-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020. Read SEC document |
| February 20, 2019 Filed Mar 8, 2019 21:35 UTC |
RIEDEL NORBERT GDirector
|
GrantStock option (right to buy) · Derivative | 12,500 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-19-018122 · doc4.xml · derivative · entry 1 RIEDEL NORBERT G · CIK 0001161662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-02-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020. Read SEC document |
| February 20, 2019 Filed Mar 8, 2019 16:31 UTC |
Troutman William WilsonCFO, Treasurer & Secretary
|
GrantStock option (right to buy) · Derivative | 95,000 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-19-018106 · doc4.xml · derivative · entry 1 Troutman William Wilson · CIK 0001756102 · CFO, Treasurer & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2029-02-19 F1 · derivative.exercise_date: The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2023. Read SEC document |
| February 20, 2019 Filed Mar 8, 2019 21:34 UTC |
MAIER PAUL VDirector
|
GrantStock option (right to buy) · Derivative | 12,500 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-19-018118 · doc4.xml · derivative · entry 1 MAIER PAUL V · CIK 0001182615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-02-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020. Read SEC document |
| February 20, 2019 Filed Mar 8, 2019 21:32 UTC |
BAUM MARK LDirector
|
GrantStock option (right to buy) · Derivative | 12,500 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-19-018109 · doc4.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-02-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020. Read SEC document |
| February 20, 2019 Filed Mar 8, 2019 21:30 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
GrantStock option (right to buy) · Derivative | 250,000 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-19-018103 · doc4.xml · derivative · entry 1 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-02-19 F1 · derivative.exercise_date: The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2021. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:24 UTC |
CASAMENTO CHARLES JDirector
|
ConversionSeries A Convertible Preferred Stock · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-058827 · doc4.xml · derivative · entry 3 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. F1 · derivative.exercise_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. F1 · derivative.expiration_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:24 UTC |
CASAMENTO CHARLES JDirector
|
PurchaseCommon Stock | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001209191-18-058827 · doc4.xml · nonDerivative · entry 2 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,420 Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:24 UTC |
CASAMENTO CHARLES JDirector
|
ConversionCommon Stock | 8,675 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-058827 · doc4.xml · nonDerivative · entry 1 CASAMENTO CHARLES J · CIK 0001117167 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:10 UTC |
RIEDEL NORBERT GDirector
|
PurchaseCommon Stock | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001209191-18-058824 · doc4.xml · nonDerivative · entry 1 RIEDEL NORBERT G · CIK 0001161662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,745 Read SEC document |
| November 15, 2018 Filed Nov 15, 2018 19:07 UTC |
Troutman William WilsonCFO, Treasurer & Secretary
|
PurchaseCommon Stock | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001209191-18-058822 · doc4.xml · nonDerivative · entry 1 Troutman William Wilson · CIK 0001756102 · CFO, Treasurer & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:06 UTC |
BAUM MARK LDirector
|
PurchaseCommon Stock | 10,000 | $6.00 | $60,000.00 |
DisclosureSEC source: 0001209191-18-058821 · doc4.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,000 Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:13 UTC |
MAIER PAUL VDirector
|
PurchaseCommon Stock | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001209191-18-058825 · doc4.xml · nonDerivative · entry 1 MAIER PAUL V · CIK 0001182615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,745 Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:23 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
ConversionSeries A Convertible Preferred Stock · Derivative | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-058826 · doc4.xml · derivative · entry 3 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by LLC Disclosed balance after: 0 Underlying: Common Stock · 24,940 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. F1 · derivative.exercise_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. F1 · derivative.expiration_date: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:23 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
PurchaseCommon Stock | 10,000 | $6.00 | $60,000.00 |
DisclosureSEC source: 0001209191-18-058826 · doc4.xml · nonDerivative · entry 2 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,000 Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 00:23 UTC |
BRYNJELSEN SEANDirector · President & CEO
|
ConversionCommon Stock | 24,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-058826 · doc4.xml · nonDerivative · entry 1 BRYNJELSEN SEAN · CIK 0001669976 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by LLC Disclosed balance after: 24,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.